DNA & RNA Banking Services Market Poised for Robust Growth, Projected to Reach USD 14+ Billion by 2030

Market Size:
The market was valued at approximately USD 7.66 billion in 2022, rising to an estimated USD 8.15 billion in 2023, with expected growth toward USD 14.34 billion by 2030, driven by a compound annual growth rate (CAGR) of around 6.5%.

Overview

DNA & RNA banking services encompass the collection, processing, transport, storage, quality control, and data management of genetic material for use in research, diagnostics, drug discovery, and therapeutic development. These services are vital to personalized medicine, biomarker discovery, and emerging therapeutic approaches like gene-editing and mRNA vaccines. The increasing global focus on precision healthcare, advanced laboratory automation, and regulatory requirements are fueling sustained market expansion.

To Know More About This Report Request A Free Sample Copy https://www.maximizemarketresearch.com/request-sample/100522/

Market Estimation & Definition

This market includes a range of service types—storage, transportation, processing, quality control, data storage, and ancillary services—covering genetic specimens such as blood, buccal swabs, hair follicles, and other biosamples. In 2022, the total market size stood at USD 7.66 billion, increasing to USD 8.15 billion in 2023, with projections reaching USD 14.34 billion by 2032 at a CAGR of 6.48%.

Market Growth Drivers & Opportunities

• Precision Medicine Expansion: Growing demand for personalized diagnostics and therapies is driving the need for secure and reliable biobanking infrastructure.
• Advancements in Therapeutics: Increased use of DNA/RNA-based therapies—such as gene editing and mRNA vaccines—is boosting demand for high-integrity biospecimens.
• Regulatory Standards & QC Requirements: Regulatory oversight has led to increased quality control efforts in sample handling and storage.
• Automation & Scale: Biobanks are integrating automated storage systems and high-throughput processing to accommodate rising sample volumes efficiently.
• Biopharma & Academic Investment: Pharmaceutical companies, biotech firms, and academic research institutions are investing heavily in biobanking services to support R&D pipelines.
• Emerging Market Development: Expansion in Asia-Pacific, Latin America, and Middle East regions offers substantial growth potential due to rising healthcare infrastructure and genomics initiatives.

Segmentation Analysis

By Service Type:

• Storage services (largest share, ~37% in 2023)
• Transportation
• Processing
• Quality control (fastest projected growth, ~6.4% CAGR)
• Data storage
• Others

By Specimen Type:

• Blood (dominant segment, ~41% share)
• Buccal swabs & hair follicles (growing fastest in CAGR)
• Others

By Application:

• Drug discovery & clinical research (largest share, ~40%)
• Therapeutics (fastest growth, driven by gene/mRNA therapies)
• Clinical diagnostics
• Other applications

By End-use Segment:

• Academic research (largest, ~36% share)
• Pharmaceutical & biotech companies
• Hospitals & diagnostic centers (fastest growth expected)
• Other end users

Major Manufacturers

• EasyDNA
• DNA Genotek, Inc.
• 23andMe, Inc.
• GoodCell
• ProteoGenex
• US Biolab Corporation, Inc.
• Infinity Biologix
• Thermo Fisher Scientific, Inc.
• deCODE genetics
• Brooks Life Sciences
• LGC Biosearch Technologies
• PreventionGenetics

These companies offer comprehensive services across storage, processing, and data management. Many have forged strategic alliances to enhance cold-chain logistics, geographic reach, and automation capabilities

Regional Analysis

North America (USA, Canada):
North America led in 2023 with over a 35% market share. Extensive genomic research infrastructure, high R&D spending, national initiatives (e.g., U.S. precision medicine biobank programs), and regulatory frameworks underpin strong market dominance.

Europe (Germany, UK, France):
Europe holds a substantial share with established research networks and supportive funding programs. Strict biobanking regulations and public-private partnerships promote market growth.

Asia-Pacific (China, India, Japan):
This region is the fastest-growing market due to rising genomics research, government-backed sequencing initiatives, and increasing healthcare investments. India and China are particularly active in expanding biobank capacity.

Latin America & Middle East/Africa:
Together these regions contribute a smaller share but are showing meaningful growth as healthcare infrastructure and awareness expand in countries like Brazil, Mexico, Saudi Arabia, and the UAE.

COVID‑19 Impact Analysis

• Surge in Biobanking Demand: COVID-19 drove urgent need for hospital- and research-grade biobanking services to support diagnostic testing and vaccine R&D.
• Rapid Expansion of Hospital Biobank Services: Hospitals and diagnostic centers accelerated onboarding of sample storage and management capabilities.
• Operational Strain and Expansion: Biobank providers enhanced cold-chain logistics, quality control systems, and remote monitoring to meet heightened demand.
• Integration with Therapeutics Research: Pharmaceutical and biotech partnerships expanded for trial-related banking and sample preservation.

Competitive (“Commutator&rdquoAnalysis

Market leaders differentiate through:

• Large-scale, automated storage infrastructure and high-throughput processing systems
• Broad geographic distribution networks and strategic alliances
• Strong regulatory compliance frameworks and quality control standards
• Offerings spanning multiple service categories (storage, QC, data management)
• Partnerships with academic, biotech, and pharmaceutical customers to co-develop sample repositories

While dominant players lead in capability and scale, smaller specialized providers serve niche applications such as boutique academic biobanks and localized hospital systems.

Key Questions Answered

1. What is the market size now and in the future?
   – Valued at USD 7.66 billion in 2022 and projected to reach around USD 14.34 billion by 2032 at ~6.5% CAGR.
2. Which service type is most prominent?
   – Storage services maintain the largest share (~37%), while quality control services are growing fastest.
3. Which specimen type dominates?
   – Blood samples account for the majority of revenue; buccal swabs and hair follicles are expanding rapidly.
4. What application segments lead the market?
   – Drug discovery and clinical research command the largest share; therapeutics is the fastest-growing segment driven by gene-based medicine needs.
5. Who are the major users of these services?
   – Academic institutions lead usage; hospitals/diagnostic centers are expected to see fastest uptake in upcoming years.
6. Which regions are most influential?
   – North America remains the largest region; Asia-Pacific supports the highest growth trajectory; Europe sustains steady development

Conclusion

The global DNA & RNA banking services market is entering a phase of robust expansion, driven by accelerating demand from personalized medicine, innovative therapeutics, genomic research, and improved healthcare infrastructure. With a value exceeding USD 7.6 billion in 2022 and projected to surpass USD 14 billion by 2032, the sector is vital to the future of biomedical science.

Providers investing in automation, geographic scalability, strict quality standards, and diversified service portfolios will be best positioned to lead. As demand spreads into emerging markets and bio-innovation grows, DNA & RNA banking forms a cornerstone of modern research, diagnostics, and therapeutic development.

About Maximize Market Research:
Maximize Market Research is a global market research and consulting company specializing in data-driven insights and strategic analysis. With a team of experienced analysts and industry experts, the company provides comprehensive reports across various sectors, aiding businesses in making informed decisions and achieving sustainable growth.

Contact Us
Maximize Market Research Pvt. Ltd.
2nd Floor, Navale IT Park, Phase 3
Pune-Bangalore Highway, Narhe
Pune, Maharashtra 411041, India
📞 +91 96073 65656
✉️ sales@maximizemarketresearch.com